• 此次撤市之后,罗塔将来美国任何使用需要FDA提交一项研究新药申请

    Following the withdrawal, any future use of Mylotarg in the United States will require submission of an investigational new drug application to FDA.

    youdao

  • 适用新药申请中,交叉验证研究数据信息

    In NDA submissions, information about cross-validation study data, if applicable.

    youdao

  • 研究基本完成了国家一类新药制剂学部分的临床前资料,处方申请专利

    The preclinical study of it as lnd category new drug of China have been finished basically and the formulation has been patented.

    youdao

  • 血液制造商开始根据FDA研究新药(IND)申请程序执行核酸检测(NAAT)。

    The Blood manufacturing community began implementation of Nucleic Acid Amplification Testing (NAAT) under the FDA's Investigational New Drug (IND) application process.

    youdao

  • 化合物研究中的申请(IND)。

    Investigational New Drug Application (IND) for the compound.

    youdao

  • 新药申请文件包含临床关键研究数据所有这些符合主要疗效终点

    The NDA file contains data from three large pivotal phase 3 studies, all of which met their co-primary efficacy endpoints.

    youdao

  • 新药申请文件包含临床关键研究数据所有这些符合主要疗效终点

    The NDA file contains data from three large pivotal phase 3 studies, all of which met their co-primary efficacy endpoints.

    youdao

$firstVoiceSent
- 来自原声例句
小调查
请问您想要如何调整此模块?

感谢您的反馈,我们会尽快进行适当修改!
进来说说原因吧 确定
小调查
请问您想要如何调整此模块?

感谢您的反馈,我们会尽快进行适当修改!
进来说说原因吧 确定